Commercial validation is the process of testing, against evidence and before committing spend, whether a real problem has a reachable buyer, an offer that buyer would choose, and economics that survive contact with the market. Market validation asks whether the problem exists. Commercial validation asks whether the commercial case around that problem holds: which buyer, which offer, which route to revenue, and at what cost.
Market validation tests whether a problem is real, visible and urgent in public market evidence. It does not establish who will buy, whether they have budget or what they will pay.
True Validation tests public market evidence only: whether the problem is real, visible and urgent. It does not prove buyer budget, willingness to pay, offer fit, acquisition economics or full commercial viability.
A potential customer who says "that sounds useful" is not yet a buyer. Commercial validation tests the case step by step: public evidence that the problem is real, visible and urgent comes first, and whether a reachable buyer exists, whether an offer maps to their complaint and whether the economics hold are tested in the later stages.
GTM Right Canvas runs commercial validation as six stages in a fixed order. True Validation is the free market-validation layer. The paid stages test the commercial layers that market validation cannot reach.

Each answers a different question about the evidence. None of them, on its own, tells you a business will succeed.
Find the situation closest to yours. Each one names the question to answer next and the page that deals with it. This is a signpost to the right question, not a score.
You are not sure the problem is real
Is the problem real, visible and urgent? (Stage 1: True Validation)
True Validation tests public market evidence only: whether the problem is real, visible and urgent. It does not prove buyer budget, willingness to pay, offer fit, acquisition economics or full commercial viability.
Test the problem with the free Stage 1 checkYou are not sure who the buyer is
Who has the problem, and who can decide to pay for a fix? (Stage 2: Buyer Precision)
The methodology explains how this stage frames the buyer question. Reading it is not evidence about your buyer; that comes only from buyers themselves.
How Buyer Precision frames the questionYou know the buyer, but not whether they will pay for your offer
Will this buyer choose this offer, at a price? (Stage 3: Buyer + Offer)
Interest, an introduction or a document labelled as a letter of intent is not automatically evidence of payment. Its weight depends on what the buyer actually committed to.
How Buyer + Offer frames the questionYou have early customers, but you do not know whether the sales will repeat
What do the results so far show, and is the demand repeatable? (Stage 4: Revenue Funnel and Stage 5: Market + Funnel)
The traction diagnosis helps you read what early results do and do not show. The later stages that test the funnel and the market are part of the paid Canvas.
Read the traction diagnosisYou need to decide whether to proceed, revise or stop
On the evidence so far, should you proceed, revise or stop? (Stage 6: Commercial Decision)
The free Stage 1 check at /start covers Stage 1 only. It does not perform the later paid stages, including this decision.
How Commercial Decision frames the questionYou do not have a formed, testable idea yet
What problem, for whom, is worth testing at all?
Idea Forge helps you form an idea worth testing. That is idea formation, not Stage 1 validation, and it produces no market evidence.
Form an idea with Idea ForgeYou have a formed idea and have not built it yet
Which assumption should you test first, and how?
The pre-build guide covers which assumptions to test, what each method can show, and what remains unproven.
Read how to validate before buildingThe two terms are often used interchangeably. They are not the same thing: evidence that a problem is real says nothing yet about who will buy, what they would choose or what they would pay.
| Dimension | Market validation | Commercial validation |
|---|---|---|
| The question asked | Is the problem real, visible and urgent? | Does the commercial case around it hold? |
| Evidence used | Public complaints, discussions and other eligible market evidence about the problem | Buyer, offer, revenue funnel and market-entry evidence, tested in the later stages |
| Buyer specificity | A segment or demographic | A named role, in a named type of company, with a route to reach it |
| What it returns | A graded view of the public evidence for the problem, and its limits | A graded evidence record across the later stages, its limits, and the next test worth running |
| Risk it addresses | Building for a problem that is not real, visible or urgent | Building for the wrong buyer, offer, or route to revenue |
| Where it stops | It does not establish who buys, whether they have budget or what they will pay | It reports evidence found, not the commercial outcome |
Market validation for startups is not a count of conversations. Sort what you find into four buckets, and keep them apart.
Eligible public evidence about the problem, such as complaints and discussions, that passes the source, relevance and integrity rules and can support the Stage 1 finding.
Relevant market signals that are useful to read but do not qualify strongly enough to change the grade. They are shown with the reason they do not count.
What a founder provides is labelled as founder-provided, not treated as external evidence. Specific observed evidence a founder reports can be credited under the grade policy, but it stays founder-provided.
What the available evidence does not establish. For market evidence this includes who will buy, whether they have budget and what they will pay, which the later stages test.
The Stage 1 grade runs Weak Signal → Medium Signal → Strong Signal. A safeguard can lower the grade a run proposes, never raise it, and a grade describes the evidence found, not the outcome.
Write the problem as a statement the evidence could contradict: who has it, when it happens and what it costs them.
Output: A falsifiable problem statement.
Look for public complaints, discussions and other eligible market evidence about that problem, and keep the source for each item.
Output: A sourced evidence list.
Look as hard for evidence against the thesis: people who do not have the problem, are content with what they use now, or describe it as minor.
Output: Evidence against the thesis.
Sort everything into qualifying evidence, discovered clues, founder assumptions and what is still unproven, and keep them separate.
Output: Evidence, clues, assumptions and unproven, kept apart.
Name the one missing piece of evidence that would most change your view, and how you would look for it.
Output: The next missing proof to seek.
In the UK, market validation is treated as one step on the way to commercialisation, not the whole case. The Government Office for Technology Transfer runs PRIMA, a market discovery programme for UK government research organisations delivered with Innovate UK, which uses market validation alongside identifying customer segments and developing value propositions.
UKRI's commercialisation guidance for researchers lists testing the market and market validation among the proof-of-concept activities that come before later-stage commercialisation.
Both are official UK context for how the term is used. Neither refers to or endorses GTM Right.
Once the public evidence for the problem is graded, the rest of the commercial case starts in the later stages:
Which specific, reachable buyer feels the pain most and can act?
Which buyer must be tested first.
What job is the offer hired for and what proves willingness to pay?
Whether the offer is right for the buyer.
Can a stranger become a paying customer with viable economics?
Whether acquisition and conversion can work commercially.
Is there a defensible entry point with viable market and funnel economics?
Where to enter and how to sustain the motion.
Are the material blockers known before capital or build spend is committed?
Whether to proceed, revise or stop.
Each stage asks one question and returns evidence against it. The order is fixed, because each question only makes sense once the one before it has an answer. These are the questions the product contract defines, stated here word for word.
Does a real market problem have credible live evidence?
Which specific, reachable buyer feels the pain most and can act?
What job is the offer hired for and what proves willingness to pay?
Can a stranger become a paying customer with viable economics?
Is there a defensible entry point with viable market and funnel economics?
Are the material blockers known before capital or build spend is committed?
A market validation record that states the evidence, limits and next test.
True Validation tests public market evidence only: whether the problem is real, visible and urgent. It does not prove buyer budget, willingness to pay, offer fit, acquisition economics or full commercial viability.
GTM Right Canvas is a one-time £349 purchase for one idea and 90 days. It includes paid work across Stages 2 to 6: Buyer Precision, Buyer + Offer, Revenue Funnel, Market + Funnel, Commercial Decision.
Stages 2 to 6 test the later commercial assumptions: Buyer Precision, Buyer + Offer, Revenue Funnel, Market + Funnel, Commercial Decision. They do not change the fact that Stage 1 is market validation only.
A graded evidence record is not a prediction and not a warranty. These are the limits the product states, and they are the same limits stated on the result itself.
Each quote is labelled with what the speaker was commenting on. None of them describes a paid engagement, and none claims a commercial result.
“Every other validation tool I have used has produced confidence; GTM Right produces evidence.”
“The Commercial Readiness Pack is the first artefact I have seen that founders, programme operators, and investors can reason about against a shared evidence standard.”
“Market feedback backed by purchase intent is the most critical factor for product-market fit. That is exactly what GTM Right holds as a brand promise.”
Product-market fit describes the state a product reaches after it has been built, distributed, and adopted. It is a retrospective measure: post-launch evidence that value is being delivered repeatedly in a market.
Commercial validation is usually done before a major commitment: before building or raising for a new idea, or, for an existing business, before a significant commercial decision such as entering a new segment. It tests the commercial conditions that product-market fit depends on. It does not make product-market fit more likely on its own. What it changes is what you know: a founder who runs it is acting on graded evidence about those conditions, and a founder who skips it is assuming them.
The distinction matters because the conditions product-market fit depends on, such as the buyer, the channel and the urgency of the pain, can be tested while changing direction is still possible.
Validation asks whether anyone will buy; product-market fit asks whether enough right-fit buyers buy repeatedly.
Validation is an umbrella term for testing a named assumption. Customer validation considers evidence from specific buyers and their behaviour. Commercial validation is the wider staged process that tests the problem, buyer, offer, funnel and commercial decision. GTM Right Stage 1 is a free public market-evidence check. It tests whether a stated problem is real, visible and urgent in public evidence. It does not establish a customer cohort, retention, willingness to pay, or product-market fit.
Product-market fit is a post-launch conclusion about a named segment and use case. It concerns whether enough right-fit buyers repeatedly choose and receive value under conditions that can continue. It is not a universal score, and it should not be generalised from one segment, channel, price point, geography, or early cohort to a wider claimed market.
A defensible product-market-fit conclusion should name, where relevant, the customer segment, cohort and denominator, value-bearing action, natural usage or renewal cadence, time period, price and material terms, acquisition or channel context, churn, cancellations and refunds, cohort maturity, and counter-evidence. The required evidence varies with the product and business model. The conclusion should remain as narrow as the evidence.
A waitlist or signups, enthusiastic interviews, a design partner, one paid pilot, founder-led sales, press or social attention, top-line growth without retention, an NPS or “very disappointed” result alone, and high early engagement can each support a narrower claim. None establishes product-market fit by itself. The missing question is whether a defined set of right-fit customers continues to choose and receive value over time.
Partial fit means the evidence is strong for a bounded segment, use case, price, geography or channel, but should not be generalised to the wider claimed market.
If you already have customers, inspect the commercial system around the evidence before treating growth as repeatable. Audit your GTM system
Need to recheck whether the problem is visible in the market? Recheck the market signal Stage 1 checks public market evidence. It does not measure retention, product-market fit, or authenticate customer cohorts.
CB Insights analysed 431 VC-backed companies that shut down since 2023. 43% cited poor product-market fit as the primary cause. That is the study's finding, stated as the study reports it.
Our reading of it, offered as a reading and not as part of the study: "poor product-market fit" is a category that hides its own causes. It can mean the wrong buyer, the wrong offer framing, the wrong channel, or the wrong urgency tier, and those are commercial questions rather than product ones. Which of them applied to any given company is not something the study reports, or something we can tell you about yours without testing it.
Commercial validation is not a confidence builder. It is an evidence collector. It shows where the commercial case stands on the evidence available, and what the next test needs to be, before a major commitment.
GTM Right Canvas runs commercial validation as six stages in a fixed order. True Validation is the free market-validation layer. The paid stages test the commercial layers that market validation cannot reach. Each stage returns what it found and what it could not establish. The output is not a pass or a fail. It is a graded evidence record that shows where the commercial case currently stands and what the next test needs to be.